vs
ANAPTYSBIO, INC(ANAB)与Repay Holdings Corp(RPAY)财务数据对比。点击上方公司名可切换其他公司
ANAPTYSBIO, INC的季度营收约是Repay Holdings Corp的1.4倍($108.2M vs $78.6M),ANAPTYSBIO, INC净利率更高(45.8% vs -178.3%,领先224.1%),ANAPTYSBIO, INC同比增速更快(151.1% vs 0.4%),ANAPTYSBIO, INC自由现金流更多($98.0M vs $23.2M),过去两年ANAPTYSBIO, INC的营收复合增速更高(288.3% vs -1.3%)
AnaptysBio是一家处于临床阶段的生物技术企业,专注于开发适用于炎症疾病、肿瘤免疫及罕见病领域的抗体类免疫疗法,主要面向美国市场,推进创新候选药物管线研发以满足未被满足的临床需求。
Repay Holdings Corp是一家聚焦北美市场的支付技术服务商,为零售、医疗、汽车服务、电商等领域的企业提供整合支付处理方案,涵盖银行卡收单、ACH转账、POS系统集成等数字化支付工具,助力客户简化交易流程、提升运营效率。
ANAB vs RPAY — 直观对比
营收规模更大
ANAB
是对方的1.4倍
$78.6M
营收增速更快
ANAB
高出150.7%
0.4%
净利率更高
ANAB
高出224.1%
-178.3%
自由现金流更多
ANAB
多$74.8M
$23.2M
两年增速更快
ANAB
近两年复合增速
-1.3%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | ||
|---|---|---|
| 营收 | $108.2M | $78.6M |
| 净利润 | $49.6M | $-140.1M |
| 毛利率 | — | 74.2% |
| 营业利润率 | 61.8% | -182.2% |
| 净利率 | 45.8% | -178.3% |
| 营收同比 | 151.1% | 0.4% |
| 净利润同比 | 327.8% | -3304.1% |
| 每股收益(稀释后) | $1.64 | $-1.68 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比,按日历期对齐,财年错位的公司也能正确匹配
营收
ANAB
RPAY
| Q4 25 | $108.2M | $78.6M | ||
| Q3 25 | $76.3M | $77.7M | ||
| Q2 25 | $22.3M | $75.6M | ||
| Q1 25 | $27.8M | $77.3M | ||
| Q4 24 | $43.1M | $78.3M | ||
| Q3 24 | $30.0M | $79.1M | ||
| Q2 24 | $11.0M | $74.9M | ||
| Q1 24 | $7.2M | $80.7M |
净利润
ANAB
RPAY
| Q4 25 | $49.6M | $-140.1M | ||
| Q3 25 | $15.1M | $-6.4M | ||
| Q2 25 | $-38.6M | $-102.3M | ||
| Q1 25 | $-39.3M | $-7.9M | ||
| Q4 24 | $-21.8M | $-4.1M | ||
| Q3 24 | $-32.9M | $3.2M | ||
| Q2 24 | $-46.7M | $-4.1M | ||
| Q1 24 | $-43.9M | $-5.2M |
毛利率
ANAB
RPAY
| Q4 25 | — | 74.2% | ||
| Q3 25 | — | 74.4% | ||
| Q2 25 | — | 75.7% | ||
| Q1 25 | — | 75.9% | ||
| Q4 24 | — | 76.3% | ||
| Q3 24 | — | 77.8% | ||
| Q2 24 | — | 78.2% | ||
| Q1 24 | — | 76.2% |
营业利润率
ANAB
RPAY
| Q4 25 | 61.8% | -182.2% | ||
| Q3 25 | 45.5% | -3.9% | ||
| Q2 25 | -117.5% | -138.7% | ||
| Q1 25 | -99.2% | -4.7% | ||
| Q4 24 | -22.4% | -1.5% | ||
| Q3 24 | -75.8% | -0.9% | ||
| Q2 24 | -367.5% | -4.6% | ||
| Q1 24 | -587.8% | -3.1% |
净利率
ANAB
RPAY
| Q4 25 | 45.8% | -178.3% | ||
| Q3 25 | 19.8% | -8.3% | ||
| Q2 25 | -173.5% | -135.2% | ||
| Q1 25 | -141.6% | -10.3% | ||
| Q4 24 | -50.5% | -5.3% | ||
| Q3 24 | -109.4% | 4.1% | ||
| Q2 24 | -425.3% | -5.4% | ||
| Q1 24 | -612.0% | -6.5% |
每股收益(稀释后)
ANAB
RPAY
| Q4 25 | $1.64 | $-1.68 | ||
| Q3 25 | $0.52 | $-0.08 | ||
| Q2 25 | $-1.34 | $-1.15 | ||
| Q1 25 | $-1.28 | $-0.09 | ||
| Q4 24 | $-0.63 | $-0.04 | ||
| Q3 24 | $-1.14 | $0.03 | ||
| Q2 24 | $-1.71 | $-0.04 | ||
| Q1 24 | $-1.64 | $-0.06 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | ||
|---|---|---|
| 现金及短期投资手头流动性 | $238.2M | $115.7M |
| 总债务越低越好 | — | $280.1M |
| 股东权益账面价值 | $37.2M | $484.4M |
| 总资产 | $364.4M | $1.2B |
| 负债/权益比越低杠杆越低 | — | 0.58× |
8季度趋势,按日历期对齐
现金及短期投资
ANAB
RPAY
| Q4 25 | $238.2M | $115.7M | ||
| Q3 25 | $109.8M | $95.7M | ||
| Q2 25 | $44.3M | $162.6M | ||
| Q1 25 | $98.6M | $165.5M | ||
| Q4 24 | $123.1M | $189.5M | ||
| Q3 24 | $191.6M | $168.7M | ||
| Q2 24 | $71.8M | $147.1M | ||
| Q1 24 | $53.7M | $128.3M |
总债务
ANAB
RPAY
| Q4 25 | — | $280.1M | ||
| Q3 25 | — | $279.5M | ||
| Q2 25 | — | $279.0M | ||
| Q1 25 | — | $497.6M | ||
| Q4 24 | — | $496.8M | ||
| Q3 24 | — | $496.2M | ||
| Q2 24 | — | $435.6M | ||
| Q1 24 | — | $434.9M |
股东权益
ANAB
RPAY
| Q4 25 | $37.2M | $484.4M | ||
| Q3 25 | $-29.4M | $616.9M | ||
| Q2 25 | $-44.7M | $633.7M | ||
| Q1 25 | $34.0M | $755.7M | ||
| Q4 24 | $70.9M | $761.3M | ||
| Q3 24 | $84.4M | $754.7M | ||
| Q2 24 | $9.9M | $815.4M | ||
| Q1 24 | $47.8M | $813.8M |
总资产
ANAB
RPAY
| Q4 25 | $364.4M | $1.2B | ||
| Q3 25 | $353.1M | $1.3B | ||
| Q2 25 | $335.3M | $1.4B | ||
| Q1 25 | $422.1M | $1.5B | ||
| Q4 24 | $483.8M | $1.6B | ||
| Q3 24 | $493.4M | $1.6B | ||
| Q2 24 | $427.4M | $1.5B | ||
| Q1 24 | $405.8M | $1.5B |
负债/权益比
ANAB
RPAY
| Q4 25 | — | 0.58× | ||
| Q3 25 | — | 0.45× | ||
| Q2 25 | — | 0.44× | ||
| Q1 25 | — | 0.66× | ||
| Q4 24 | — | 0.65× | ||
| Q3 24 | — | 0.66× | ||
| Q2 24 | — | 0.53× | ||
| Q1 24 | — | 0.53× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | ||
|---|---|---|
| 经营现金流最新季度 | $98.0M | $23.3M |
| 自由现金流经营现金流 - 资本支出 | $98.0M | $23.2M |
| 自由现金流率自由现金流/营收 | 90.5% | 29.6% |
| 资本支出强度资本支出/营收 | 0.0% | 0.1% |
| 现金转化率经营现金流/净利润 | 1.98× | — |
| 过去12个月自由现金流最近4个季度 | $19.6M | $90.7M |
8季度趋势,按日历期对齐
经营现金流
ANAB
RPAY
| Q4 25 | $98.0M | $23.3M | ||
| Q3 25 | $-27.4M | $32.2M | ||
| Q2 25 | $-40.2M | $33.1M | ||
| Q1 25 | $-10.7M | $2.5M | ||
| Q4 24 | $-66.7M | $34.3M | ||
| Q3 24 | $-10.1M | $60.1M | ||
| Q2 24 | $-21.3M | $31.0M | ||
| Q1 24 | $-37.3M | $24.8M |
自由现金流
ANAB
RPAY
| Q4 25 | $98.0M | $23.2M | ||
| Q3 25 | $-27.4M | $32.1M | ||
| Q2 25 | $-40.3M | $33.0M | ||
| Q1 25 | $-10.7M | $2.4M | ||
| Q4 24 | $-66.9M | $34.0M | ||
| Q3 24 | $-10.1M | $59.8M | ||
| Q2 24 | $-21.4M | $30.5M | ||
| Q1 24 | $-37.3M | $24.7M |
自由现金流率
ANAB
RPAY
| Q4 25 | 90.5% | 29.6% | ||
| Q3 25 | -35.9% | 41.3% | ||
| Q2 25 | -180.9% | 43.6% | ||
| Q1 25 | -38.7% | 3.0% | ||
| Q4 24 | -155.3% | 43.5% | ||
| Q3 24 | -33.7% | 75.6% | ||
| Q2 24 | -194.6% | 40.7% | ||
| Q1 24 | -519.3% | 30.6% |
资本支出强度
ANAB
RPAY
| Q4 25 | 0.0% | 0.1% | ||
| Q3 25 | 0.0% | 0.2% | ||
| Q2 25 | 0.2% | 0.1% | ||
| Q1 25 | 0.1% | 0.2% | ||
| Q4 24 | 0.6% | 0.3% | ||
| Q3 24 | 0.1% | 0.3% | ||
| Q2 24 | 0.3% | 0.6% | ||
| Q1 24 | 0.4% | 0.1% |
现金转化率
ANAB
RPAY
| Q4 25 | 1.98× | — | ||
| Q3 25 | -1.81× | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 18.52× | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
ANAB
暂无分部数据
RPAY
| Sales Channel Directly To Consumer | $69.4M | 88% |
| Other | $6.8M | 9% |
| Sales Channel Through Intermediary | $2.3M | 3% |